Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review

BACKGROUND: Unabridged access to drug industry and regulatory trial registers and data reduces reporting bias in systematic reviews and may provide a complete index of a drug’s clinical study programme. Currently, there is no public index of the human papillomavirus (HPV) vaccine industry study prog...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Syst Rev
Hlavní autoři: Jørgensen, Lars, Gøtzsche, Peter C., Jefferson, Tom
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5774129/
https://ncbi.nlm.nih.gov/pubmed/29347995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-018-0675-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky